Grant: Operating Grant
University of British Columbia
$261,191.00
The Impact of a Physician Detailing and Sampling Program for Generic Atorvastatin
FY 2012-13
Summary
Generic drugs provide a savings opportunity that is underutilized in Canada. While generics represent over 80% of prescriptions dispensed in the United States, Canadian rates are much lower at around 60%. In 2010, Manitoba Health implemented an innovative program aimed at increasing the use of generic atorvastatin. Our study will investigate the effects of this physician detailing and sampling program on statin utilization and costs, market share of generic statins, and the choice of starting statin.
Department
Program
Operating Grant
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
266663
Name
Law Michael R
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Services Evaluation & Interventions Research
Projecttitle
The Impact of a Physician Detailing and Sampling Program for Generic Atorvastatin
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$261,191
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Generic Drugs; Health Care Costs; Health Services Research; Pharmaceutical Marketing; Prescription Drugs
Abstract
Generic drugs provide a savings opportunity that is underutilized in Canada. While generics represent over 80% of prescriptions dispensed in the United States, Canadian rates are much lower at around 60%. In 2010, Manitoba Health implemented an innovative program aimed at increasing the use of generic atorvastatin. Our study will investigate the effects of this physician detailing and sampling program on statin utilization and costs, market share of generic statins, and the choice of starting statin.
Competitiondate
201209
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Law, Michael R
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $261,191~ $0~
